Internal iliac artery revascularisation versus internal iliac artery occlusion for endovascular treatment of aorto-iliac aneurysms.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
21 07 2020
Historique:
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 26 9 2020
Statut: epublish

Résumé

Endovascular aortic aneurysm repair (EVAR) is used to treat aorto-iliac and isolated iliac aneurysms in selected patients, and prospective studies have shown advantages compared with open surgical repair, mainly in the first years of follow-up. Although this technique produces good results, anatomic issues (such as common iliac artery ectasia or an aneurysm that involves the iliac bifurcation) can make EVAR more complex and challenging and can lead to an inadequate distal seal zone for the stent-graft. Inadequate distal fixation in the common iliac arteries can lead to a type Ib endoleak. To avoid this complication, one of the most commonly used techniques is unilateral or bilateral internal iliac artery occlusion and extension of the iliac limb stent-graft to the external iliac arteries with or without embolisation of the internal iliac artery. However, this occlusion is not without harm and is associated with ischaemic complications in the pelvic territory such as buttock claudication, sexual dysfunction, ischaemic colitis, gluteal necrosis, and spinal cord injury. New endovascular devices and alternative techniques such as iliac branch devices and the sandwich technique have been described to maintain pelvic perfusion and decrease complications, achieving revascularisation of the internal iliac arteries in patients not suitable for an adequate seal zone in the common iliac arteries. These approaches may also preserve the quality of life of treated individuals and may decrease other serious complications including spinal cord ischaemia, ischaemic colitis, and gluteal necrosis, thereby decreasing the morbidity and mortality of EVAR. To assess the effects of internal iliac artery revascularisation versus internal iliac artery occlusion during endovascular repair of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation. The Cochrane Vascular Information Specialists searched the Cochrane Vascular Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library; MEDLINE; Embase; the Cumulative Index to Nursing and Allied Health Literature (CINAHL); and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 28 August 2019. The review authors searched Latin American Caribbean Health Sciences Literature (LILACS) and the Indice Bibliográfico Español de Ciencias de la Salud (IBECS) on 28 August 2019 and contacted specialists in the field and manufacturers to identify relevant studies. We planned to include all randomised controlled trials (RCTs) that compared internal iliac artery revascularisation with internal iliac artery occlusion for patients undergoing endovascular treatment of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation. Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions. We identified no RCTs that met the inclusion criteria. We found no RCTs that compared internal iliac artery revascularisation versus internal iliac artery occlusion for endovascular treatment of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation. High-quality studies that evaluate the best strategy for managing endovascular repair of aorto-iliac aneurysms with inadequate distal seal zones in the common iliac artery are needed.

Sections du résumé

BACKGROUND
Endovascular aortic aneurysm repair (EVAR) is used to treat aorto-iliac and isolated iliac aneurysms in selected patients, and prospective studies have shown advantages compared with open surgical repair, mainly in the first years of follow-up. Although this technique produces good results, anatomic issues (such as common iliac artery ectasia or an aneurysm that involves the iliac bifurcation) can make EVAR more complex and challenging and can lead to an inadequate distal seal zone for the stent-graft. Inadequate distal fixation in the common iliac arteries can lead to a type Ib endoleak. To avoid this complication, one of the most commonly used techniques is unilateral or bilateral internal iliac artery occlusion and extension of the iliac limb stent-graft to the external iliac arteries with or without embolisation of the internal iliac artery. However, this occlusion is not without harm and is associated with ischaemic complications in the pelvic territory such as buttock claudication, sexual dysfunction, ischaemic colitis, gluteal necrosis, and spinal cord injury. New endovascular devices and alternative techniques such as iliac branch devices and the sandwich technique have been described to maintain pelvic perfusion and decrease complications, achieving revascularisation of the internal iliac arteries in patients not suitable for an adequate seal zone in the common iliac arteries. These approaches may also preserve the quality of life of treated individuals and may decrease other serious complications including spinal cord ischaemia, ischaemic colitis, and gluteal necrosis, thereby decreasing the morbidity and mortality of EVAR.
OBJECTIVES
To assess the effects of internal iliac artery revascularisation versus internal iliac artery occlusion during endovascular repair of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation.
SEARCH METHODS
The Cochrane Vascular Information Specialists searched the Cochrane Vascular Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library; MEDLINE; Embase; the Cumulative Index to Nursing and Allied Health Literature (CINAHL); and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 28 August 2019. The review authors searched Latin American Caribbean Health Sciences Literature (LILACS) and the Indice Bibliográfico Español de Ciencias de la Salud (IBECS) on 28 August 2019 and contacted specialists in the field and manufacturers to identify relevant studies.
SELECTION CRITERIA
We planned to include all randomised controlled trials (RCTs) that compared internal iliac artery revascularisation with internal iliac artery occlusion for patients undergoing endovascular treatment of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation.
DATA COLLECTION AND ANALYSIS
Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions.
MAIN RESULTS
We identified no RCTs that met the inclusion criteria.
AUTHORS' CONCLUSIONS
We found no RCTs that compared internal iliac artery revascularisation versus internal iliac artery occlusion for endovascular treatment of aorto-iliac aneurysms and isolated iliac aneurysms involving the iliac bifurcation. High-quality studies that evaluate the best strategy for managing endovascular repair of aorto-iliac aneurysms with inadequate distal seal zones in the common iliac artery are needed.

Identifiants

pubmed: 32691854
doi: 10.1002/14651858.CD013168.pub2
pmc: PMC7389186
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD013168

Subventions

Organisme : Chief Scientist Office
ID : ETM/442
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):728-34
pubmed: 18338212
Arch Surg. 1978 Nov;113(11):1289-93
pubmed: 708250
Cochrane Database Syst Rev. 2020 Jul 21;7:CD013168
pubmed: 32691854
J Endovasc Ther. 2006 Jun;13(3):415-9
pubmed: 16784331
Ann Vasc Surg. 2004 Mar;18(2):143-6
pubmed: 15253247
J Vasc Interv Radiol. 2016 Feb;27(2):174-80
pubmed: 26706185
J Endovasc Ther. 2011 Feb;18(1):106-11
pubmed: 21314358
J Endovasc Ther. 2011 Feb;18(1):114-20
pubmed: 21314360
Perspect Vasc Surg Endovasc Ther. 2011 Sep;23(3):214-22
pubmed: 21502113
J Vasc Surg. 2018 Jan;67(1):2-77.e2
pubmed: 29268916
Ann R Coll Surg Engl. 2014 Mar;96(2):116-20
pubmed: 24780668
Perspect Vasc Surg Endovasc Ther. 2011 Sep;23(3):166-72
pubmed: 21810808
J Vasc Surg. 2000 Jan;31(1 Pt 1):114-21
pubmed: 10642714
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Eur J Vasc Endovasc Surg. 2017 Apr;53(4):534-548
pubmed: 28242154
Cochrane Database Syst Rev. 2014 Jan 23;(1):CD004178
pubmed: 24453068
Ann Surg. 1966 Oct;164(4):678-99
pubmed: 5924789
J Vasc Surg. 2004 Oct;40(4):698-702
pubmed: 15472597
J Vasc Surg. 2008 Jun;47(6):1203-1210; discussion 1210-1
pubmed: 18514838
J Vasc Surg. 2009 May;49(5):1154-61
pubmed: 19394544
Eur J Vasc Endovasc Surg. 2012 Mar;43(3):287-92
pubmed: 22240335
J Vasc Interv Radiol. 2007 Dec;18(12):1481-6
pubmed: 18057281
Vestn Khir Im I I Grek. 1986 Nov;137(11):123-5
pubmed: 3824776
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
J Vasc Surg. 2014 May;59(5):1181-93
pubmed: 24440678
J Vasc Surg. 1999 Oct;30(4):632-40
pubmed: 10514202
Eur J Vasc Endovasc Surg. 2011 Jan;41 Suppl 1:S1-S58
pubmed: 21215940
J Vasc Surg. 1991 Mar;13(3):452-8
pubmed: 1999868
J Vasc Surg. 2001 May;33(5):921-6
pubmed: 11331829
Eur J Vasc Endovasc Surg. 2016 Nov;52(5):621-634
pubmed: 27600731
Eur J Vasc Endovasc Surg. 1998 Mar;15(3):255-7
pubmed: 9587341
Ann Vasc Surg. 1991 Nov;5(6):491-9
pubmed: 1837729
Ann Vasc Surg. 2016 May;33:18-22
pubmed: 26952776
Semin Vasc Surg. 2016 Mar;29(1-2):3-17
pubmed: 27823587
J Vasc Surg. 2004 Oct;40(4):703-9; discussion 709-10
pubmed: 15472598
J Vasc Surg. 2001 Jul;34(1):98-105
pubmed: 11436081
J Endovasc Ther. 2017 Jun;24(3):405-410
pubmed: 28511617
Perspect Vasc Surg Endovasc Ther. 2012 Jun;24(2):55-62
pubmed: 23196714
J Vasc Surg. 2002 May;35(5):1048-60
pubmed: 12021727
Eur J Vasc Endovasc Surg. 2009 Feb;37(2):182-8
pubmed: 19046903
Cardiovasc Surg. 1995 Apr;3(2):109-14
pubmed: 7606394
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Luiz Henrique Dg Sousa (LHD)

Department of Surgery, Division of Vascular and Endovascular Surgery, Universidade Federal de São Paulo, São Paulo, Brazil.

Jose Cc Baptista-Silva (JC)

Evidence Based Medicine, Cochrane Brazil, Universidade Federal de São Paulo, São Paulo, Brazil.

Vladimir Vasconcelos (V)

Department of Surgery, Division of Vascular and Endovascular Surgery, Universidade Federal de São Paulo, São Paulo, Brazil.

Ronald Lg Flumignan (RL)

Department of Surgery, Division of Vascular and Endovascular Surgery, Universidade Federal de São Paulo, São Paulo, Brazil.

Luis Cu Nakano (LC)

Department of Surgery, Division of Vascular and Endovascular Surgery, Universidade Federal de São Paulo, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH